Pharmacologic stress echocardiography in the assessment of coronary artery disease

Current Opinion in Cardiology

Volumn 14, Issue 6, 1999, Pages 464-470

  Picano, Eugenio ^a   Trivieri, Maria Giovanna ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOTONIC AGENT; DIAGNOSTIC AGENT; DIPYRIDAMOLE; DOBUTAMINE; VASODILATOR AGENT;

CLINICAL TRIAL; COMPARATIVE STUDY; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; EXERCISE TEST; FEMALE; HUMAN; MALE; METHODOLOGY; PROGNOSIS; REVIEW; SENSITIVITY AND SPECIFICITY;

CARDIOTONIC AGENTS; CLINICAL TRIALS; CORONARY DISEASE; DIPYRIDAMOLE; DOBUTAMINE; ECHOCARDIOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; MALE; PROGNOSIS; SENSITIVITY AND SPECIFICITY; VASODILATOR AGENTS;

EID: 0033220088     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-199911000-00003     Document Type: Article

References (47)

1. Picano E: Stress Echocardiography, edn 3. Heidelberg: Springer Verlag; 1997.
2. Picano E: Stress echocardiography: from pathophysiological toy to diagnostic tool. Point of view. Circulation 1992, 85:1604-1612.
3. Pingitore A, Picano E, Quarta Colosso M, Reisenhofer B, Gigli G, Lucarini AR, et al.: The atropine factor in pharmacological stress echocardiography. J Am Coll Cardiol 1996, 27:1164-1170.
4. Lu C, Picano E, Pingitore A, Sicari R, Tongiani R, Baratto M, et al.: Complex artery coronary lesion morphology influences results of stress echocardiography. Circulation 1995, 91:1669-1675.
5. Varga A, Picano E, Sicari R, Gliozheni E, Palmieri C, Marzilli M: The relative role of coronary stenosis severity and morphology in determining pharmacological stress echo positivity. Am J Cardiol 1998, 82:166-171.
6. Beleslin B, Ostojic M, Djordjevic-Dikic A, et al.: The relative role of coronary artery stenosis severity and morphology in determining pharmacological stress echo positivity. J Am Coll Cardiol 1999;33:717-726.
7. Gliozheni E, Picano E, Bernardino L, Pingitore A, Sicari R, Marzilli M: Angiographically assessed coronary collateral circulation increases vulnerability to myocardial ischemia during vasodilator stress testing. Am J Cardiol 1996, 78:1419-1424.
8. Lattanzi F, Picano E, Bolognese L, Piccinino C, Sarasso G, Orlandini A, L'Abbate A: Inhibition of dipyridamole-induced ischemia by antianginal therapy in humans. Correlation with exercise electrocardiography. Circulation 1991, 83:1256-1262.
9. Ferrara N, Coltorti F, Leosco D, et al.: Protective effects of beta-blockade on dipyridamole-induced myocardial ischemia. Role of heart rate. Eur Heart J 1995, 16:903-908.
10. Dodi C, Pingitore A, Sicari R, Bruno G, Cordovil A, Picano E: Effects of antianginal therapy with calcium-antagonist and nitrates on dobutamine-atropine stress echocardiography: comparison with exercise electrocardiography. Eur Heart J 1997, 18:242-247.
11. Fioretti PM, Poldermans D, Salustri A, Forster T, Boersma E, McNeill AJ, et al.: Atropine increases the accuracy of dobutamine stress echocardiography in patients taking beta blockers. Eur Heart J 1994, 15:355-360.
12. Varga A, Preda I: Pharmacological stress echocardiography for exercise independent assessment of anti-ischaemic therapy. Eur Heart J 1997, 18:180-181.
13. San Roman RA, Villacosta I, Castillo JA: Dipyridamole and dobutamine-atropine stress echocardiography in the diagnosis of coronary artery disease. Comparison with exercise stress test, analysis of agreement and impact on antianginal treatment. Chest 1996, 110:1248-1254.
14. Picano E, Sicari R, Varga A: Dipyridamole stress echocardiography. Cardiol Clin North Am 1999, 17:481-499.
15. Picano E, Bedetti G, Varga A, Cseh E: The comparable diagnostic accuracy of dobutamine and dipyridamole stress echocardiography: a meta-analysis. Coron Artery Dis 1999, in press.
16. Martin TW, Seaworth JF, Johns JP, Pupa LE, Condos WR: Comparison of adenosine, dipyridamole and dobutamine in stress echocardiography. Ann Intern Med 1992, 116:190-196.
17. Schroder K, Voller H, Dingerkus H, Munzenberg H, Dissman R, Linderer T, Schulteiss HP: Comparison of the diagnostic potential of four echocardiographic stresses shortly after myocardial infarction: submaximal exercise, transesophageal atrial pacing, dipyridamole and dobutamine-atropine. Am J Cardiol 1996, 77:909-914.
18. Sochowskl RA, Yvorchuck KJ, Yang Y: Dobutamine and dipyridamole stress echocardiography in patients with a low incidence of coronary artery disease. J Am Soc Echocardiogr 1995, 8:482-487.
19. Beleslin BD, Ostojic M, Stepanovic J, Djordjevic-Dikic A, Stojkovic S, Babic R, et al.: Stress echocardiography in the diagnosis of detection of ischemic heart disease: head-to-head comparison between exercise, dobutamine and dipyridamole test. Circulation 1994, 90:1168-1174.
20. Parodi G, Picano E, Marcassa C, et al.: High dose dipyridamole myocardial imaging: simultaneous sestamibi scintigraphy and two-dimensional echocardiography in the detection and evaluation of coronary artery stenosis. Coron Artery Dis 1999, 10:177-184.
21. San Roman JA, Villacosta I, Castillo JA, Rollan MJ, Hernandez M, Peral V, et al.: Selection of the optimal stress test for the diagnosis of coronary artery disease. Heart 1998, 80:370-376.
22. Torres MA, Picano E, Parodi G, Sicari R, Veglia F, Giorgetti A, et al.: The flow-functional relationship in patients with chronic coronary artery disease and reduced regional function: a positron emission tomography and two-dimensional echocardiography study with coronary vasodilator stress. J Am Coll Cardiol 1997, 30:65-70
23. Minardi G, Di Segni M, Manzara CC, Pulignano G, Chiantera A, De Santis F, et al.: Diagnostic and prognostic value of dipyridamole and dobutamine stress echocardiography in patients with acute myocardial infarction. Am J Cardiol 1997, 80:847-851.
24. Poli A, Previtali M, Lanzarini L, et al.: Comparison of dobutamine stress echocardiography with dipyridamole stress echocardiography for detection of viable myocardium after myocardial infarction treated with thrombolysis, Heart 1996, 75:240-245.
25. Sicari R, Varga A, Picano E, et al.: Comparison of combination of dipyridamole and dobutamine during echocardiography with thallium scintigraphy to improve viability detection. Am J Cardiol 1999, 83:6-10
26. Picano E, Ostojic M, Varga A, et al.: Combined low dose dipyridamole-dobutamine echocardiography: a new stress for myocardial viability identification by pharmacological stress echocardiography. J Am Coll Cardiol 1996, 27:142-148.
27. Schroeder K, Wieckhorst A, Voller H: Comparison of the prognostic value of dipyridamole and dobutamine stress echocardiography in patients with known or suspected coronary artery disease. Am J Cardiol 1997, 79:1516-1518.
28. Pingitore A, Picano E, Varga A, Gigli G, Cortigiani L, Previtali M, et al.: Prognostic value of pharmacological stress echocardiography in patients with known or suspected coronary artery disease: a prospective, large scale, multicenter, head-to-head comparison between dipyridamole and dobutamine test. J Am Coll Cardiol 1999, in press.
29. Beleslin BD, Ostojic M, Djordjevic-Dikic A, et al.: Coronary vasodilation without myocardial erection: simultaneous hemodynamic, echocardiographic and arteriographic findings during adenosine and dipyridamole infusion. Eur Heart J 1997, 18:1166-1174.
30. Djorkievic-Dikic A, Ostojic M, Beleslin BD, et al.: High dose adenosine stress echocardiography for noninvasive detection of coronary artery disease. J Am Coll Cardiol 1996, 28:1689-1695.
31. Cortigiani L, Dodi C, Paolini EA, Bernardi D, Bruno G, Nannini E: Prognostic value of pharmacological stress echocardiography in women with chest pain and unknown coronary artery disease. J Am Coll Cardiol 1998, 32:1975-1981.
32. Cortigiani L, Paolini EA, Nannini E: Dipyridamole stress echocardiography for risk stratification in hypertensive patients with chest pain. Circulation 1998, 98:2855-2859.
33. Poldermans D, Fioretti PM, Boersma E, Bax JJ, Thomson IR, Roelandt JR, Simoons ML: Long-term prognostic value of dobutamine-atropine stress echocardiography in 1737 patients with known or suspected coronary artery disease: a single-center experience. Circulation 1999, 99:757-762.
34. Sicari R, Ripofi A, Picano E, Djordjevic-Dikic A, Di Giovanbattista R, Minardi G, et al.:Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large scale multicenter study on 509 patients. Circulation 1999, in press.
35. Cortigiani L, Picano E, Landi P, Previtali M, Pirelli S, Bellotti P, et al.: Value of pharmacological stress echocardiography in risk stratification of patients with single-vessel disease. A report from the Echo-Persantine and Echo-Dobutamine International Cooperative studies. J Am Coll Cardiol 1998, 32:69-74
36. Chuah SC, Pellikka PA, Roger VL, Mc Cutty RB, Seward JB: Role of dobutamine stress echocardlography in predicting outcome of 860 patients with known or suspected coronary artery disease. Circulation 1998, 97:1474-1480.
37. Sicari R, Picano E, Landi P, Pingitore A, Bigi R, Coletta C, et al.: Prognostic value of dobutamine-atropine stress echocardiography early after acute myocardial infarction. J Am Coll Cardio! 1997, 29:254-260.
38. Picano E, Sicari R, Landi P, Cortigiani L, Bigi R, Coletta C, et al.: The prognostic value of myocardial viability in medically treated patients with global left ventricular dysfunction early after an acute uncomplicated myocardial infarction: a dobutamine stress echocardiographic study. Circulation 1998, 98:1078-1094.
39. Marwick TH, Zuchowski C, Lauer MS, Secknus MA, Williams J, Lytle BW: Functional status and quality of life in patients with heart failure undergoing coronary artery bypass surgery after assessment of myocardial viability. J Am Coll Cardiol 1999, 33:750-758.
40. Meluzin J, Cerny J, Frelich M, Stetka F, Spinarova L, Popelova J, Stipal R: Prognostic value of the amount of dysfunctional but viable myocardium in revascularized patients with coronary artery disease and left ventricular dysfunction. J Am Coll Cardiol 1998, 32:912-920.
41. Afridi I, Grayburn PA, Panza JA, Oh JK, Zoghbi WA, Marwick TH: Myocardial viability during dobutamine echocardiography predicts survival in patients with coronary artery disease and severe left ventricular systolic dysfunction. J Am Coll Cardiol 1998, 32:921-926.
42. Belardinelli R, Georgiou D, Purcaro A: Low dose dobutamine echocardiography predicts improvement in functional capacity after exercise training in patients with ischemic cardiomyopathy: prognostic implications. J Am Coll Cardiol 1998, 31:1027-1034.
43. Picano E, Mathias W Jr, Pingitore A, Bigi R, Previtali M, et al.: Safety and tolerability of dobutamine-atropine stress echocardiography: a prospective, large scale, multicenter trial. Lancet 1994, 344:1190-1192.
44. Picano E, Marini C, Pirelli S, Maffei S, Bolognese L, Chiriatti GP, et al.: Safety of intravenous high-dose dipyridamole echocardiography. Am J Cardiol 1992, 70:252-256.
45. Lattanzi F, Picano E, Adamo E, Varga A: Dobutamine stress echocardiography: safety in diagnosing coronary artery disease. Drug Safety Review 1999, in press.
46. Galloway MT, Paglieroni TG, Wun T, Arena FJ, Lewis WR: Platelet activation during dobutamine stress echocardiography. Am Heart J 1998, 135:888-900.
47. Varga A, Picano E, Dodi C, Barbicri A, Pratali L, Gaddi O: Madness and method in stress echo reading. Eur Heart J 1999, 20:1271-1275.